Dr. Emilio A. Torres-Netto, MD, PhD, FWCRS, a cornea, cataract, and refractive surgeon at the ELZA Institute in Zurich, has been recognized as a TouchOphthalmology Future Leader 2025. This initiative highlights early-career ophthalmologists whose contributions to research, innovation, education, and clinical practice are shaping the future of the field.
TouchOphthalmology Future Leader 2025 honoree Dr. Torres-Netto was selected by TouchOphthalmology’s editorial board and faculty for his groundbreaking work in developing advanced therapeutic strategies for keratoconus, corneal cross-linking, and refractive surgery. His translational research bridges laboratory science with clinical application, improving patient outcomes and expanding treatment possibilities.
Dr. Torres-Netto earned his medical degree from the Federal University of São Paulo, Brazil, and pursued further training in ophthalmology across multiple renowned institutions, including Stanford University, Fondation Ophtalmologique Adolphe de Rothschild in Paris, and the University of Zurich. His diverse international background has equipped him with a broad understanding of global ophthalmic practices and cutting-edge technologies in corneal and refractive surgery.
Throughout his career, Dr. Torres-Netto has been mentored by leading experts, including Prof. Farhad Hafezi, with whom he collaborates on corneal biomechanics and novel treatment protocols. His research has led to significant advances, such as the sub-400 protocol for thin corneas and the ELZA-PACE cross-linking technique, both of which are now utilized internationally. Additionally, his work at the Center for Applied Biotechnology and Molecular Medicine (CABMM) at the University of Zurich focuses on developing personalized therapeutic approaches for complex corneal pathologies.
In addition to his clinical and research activities, Dr. Torres-Netto has received several awards for his contributions to ophthalmology, including the Waring Memorial Award from the International Society of Refractive Surgery and the American Academy of Ophthalmology Achievement Award. His extensive contributions to peer-reviewed literature and book chapters reflect his commitment to advancing ophthalmic knowledge and improving patient care.
Fluent in multiple languages, including German, French, Spanish, Portuguese, and English, Dr. Torres-Netto is able to engage with a diverse patient population and collaborate effectively with international research teams. His work continues to influence the field, improving patient care and shaping the next generation of ophthalmic treatments.
The TouchOphthalmology Future Leader 2025 recognition underscores Dr. Torres-Netto’s dedication to advancing ophthalmology through innovation and scientific inquiry. His research and clinical expertise continue to push the boundaries of corneal surgery, offering new hope for patients worldwide.
Read TouchOphthalmology’s interview with Dr. Torres-Netto aqui.
